<VariationArchive VariationID="7407" VariationName="NM_006941.4(SOX10):c.506del (p.Pro169fs)" VariationType="Deletion" Accession="VCV000007407" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2016-09-24" MostRecentSubmission="2016-09-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22446" VariationID="7407">
      <GeneList>
        <Gene Symbol="POLR2F" FullName="RNA polymerase II, I and III subunit F" GeneID="5435" HGNC_ID="HGNC:9193" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>22q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="37953663" stop="38041915" display_start="37953663" display_stop="38041915" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38349673" stop="38365318" display_start="38349673" display_stop="38365318" Strand="+" />
          </Location>
          <OMIM>604414</OMIM>
        </Gene>
        <Gene Symbol="SOX10" FullName="SRY-box transcription factor 10" GeneID="6663" HGNC_ID="HGNC:11190" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>22q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="37972312" stop="37984555" display_start="37972312" display_stop="37984555" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38368318" stop="38380538" display_start="38368318" display_stop="38380538" Strand="-" />
          </Location>
          <OMIM>602229</OMIM>
          <Haploinsufficiency last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX10">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX10">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006941.4(SOX10):c.506del (p.Pro169fs)</Name>
      <CanonicalSPDI>NC_000022.11:37978057:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="37978058" stop="37978058" display_start="37978058" display_stop="37978058" variantLength="1" positionVCF="37978057" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="38374065" stop="38374065" display_start="38374065" display_stop="38374065" variantLength="1" positionVCF="38374064" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P169fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.38374067del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.38374067del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.37978060del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.37978060del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007948.1" sequenceAccession="NG_007948" sequenceVersion="1" change="g.11475del">
            <Expression>NG_007948.1:g.11475del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006941.3" sequenceAccession="NM_006941" sequenceVersion="3" change="c.504delC">
            <Expression>NM_006941.3:c.504delC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008872.1" sequenceAccession="NP_008872" sequenceVersion="1" change="p.Pro169Argfs">
            <Expression>NP_008872.1:p.Pro169Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006941.4" sequenceAccession="NM_006941" sequenceVersion="4" change="c.506del" MANESelect="true">
            <Expression>NM_006941.4:c.506del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008872.1" sequenceAccession="NP_008872" sequenceVersion="1" change="p.Pro169fs">
            <Expression>NP_008872.1:p.Pro169fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363825.1" sequenceAccession="NM_001363825" sequenceVersion="1" change="c.*38+5750del">
            <Expression>NM_001363825.1:c.*38+5750del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001301130.2" sequenceAccession="NM_001301130" sequenceVersion="2" change="c.294-8094del">
            <Expression>NM_001301130.2:c.294-8094del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001301131.2" sequenceAccession="NM_001301131" sequenceVersion="2" change="c.293+10890del">
            <Expression>NM_001301131.2:c.293+10890del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_271" sequenceAccession="LRG_271">
            <Expression>LRG_271:g.11475del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_271t1" sequenceAccession="LRG_271t1">
            <Expression>LRG_271t1:c.506del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA118778" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602229.0015" DB="OMIM" />
        <XRef Type="rs" ID="397515369" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006941.4(SOX10):c.506del (p.Pro169fs) AND Waardenburg syndrome type 2E, without neurologic involvement" Accession="RCV000007832" Version="13">
        <ClassifiedConditionList TraitSetID="2015">
          <ClassifiedCondition DB="MedGen" ID="CN069052">Waardenburg syndrome type 2E, without neurologic involvement</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2008-08-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-09-24" MostRecentSubmission="2016-09-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18627047</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2015" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10320" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Waardenburg syndrome type 2E, without neurologic involvement</ElementValue>
              </Name>
              <XRef ID="CN069052" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28037" SubmissionDate="2016-09-21" DateLastUpdated="2016-09-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602229.0015_WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT" title="SOX10, 1-BP DEL, 506C_WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT" />
        <ClinVarAccession Accession="SCV000028037" DateUpdated="2016-09-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-08-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Japanese girl with Waardenburg syndrome type 2E (611584), Iso et al. (2008) identified a heterozygous 1-bp deletion (506delC) in exon 4 of the SOX10 gene, predicted to result in a frameshift and premature termination that would remove the C-terminal part of the HMG domain and the whole transactivation domain. She had ocular albinism, a white forelock, and sensorineural deafness.</Attribute>
              <Citation>
                <ID Source="PubMed">18627047</ID>
              </Citation>
              <XRef DB="OMIM" ID="611584" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX10" />
          </GeneList>
          <Name>SOX10, 1-BP DEL, 506C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 506C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602229.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="28037" TraitType="Disease" MappingType="Name" MappingValue="WAARDENBURG SYNDROME, TYPE 2E, WITHOUT NEUROLOGIC INVOLVEMENT" MappingRef="Preferred">
        <MedGen CUI="CN069052" Name="Waardenburg syndrome type 2E, without neurologic involvement" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

